We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Johnson & Johnson Submits Its First HIV Drug NDA
Johnson & Johnson Submits Its First HIV Drug NDA
January 6, 2006
Johnson & Johnson (J&J) has filed its first application to market an HIV drug, one of three being developed by its European subsidiary, Tibotec Pharmaceuticals, which J&J bought in 2002.